Detalhe da pesquisa
1.
R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
J Pathol
; 258(3): 289-299, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106661
2.
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Gut
; 66(6): 1095-1105, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511199
3.
MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.
Nat Genet
; 39(6): 759-69, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17468756
4.
Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
Oncogene
; 37(12): 1594-1609, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326437
5.
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.
Nat Commun
; 7: 13567, 2016 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27876799
6.
Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
Oncogene
; 23(36): 6047-55, 2004 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-15208658
7.
Analysis of tumor heterogeneity and cancer gene networks using deep sequencing of MMTV-induced mouse mammary tumors.
PLoS One
; 8(5): e62113, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690930